Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ash_5760
    Junior Member
    • Aug 2012
    • 3

    Input DNA smaller than ChIP DNA

    Hi all,
    I will be doing ChIP-seq for several transcription factors and I am in the ChIP process now. I have done sonication using the covaris S2 along with microTubes w/AFA that hold 130ul. I sonicated 1x10^7 cells in 130ul and did a time course at 10% duty cycle, 200 cycles/burst, intensity=5. I ended up using an 8min sonication with these conditions to shear to ~200-800bp fragments. I did ChIP for 2 different TFs in parallel and when I ran them out on the bioanalyzer, I saw that the input was sheared to 200-300bp but the ChIP peaks were from 2000-7000bp. I am wondering why I am not pulling down anything in the 200-800bp range? I attached the bioA image where the first 8 lanes are the ChIPs and lanes 9 and 10 are the inputs. I am planning to make illumina libraries and sequence samples so my concern is that when I do the size selection step using the TruSeq ChIP kit, I will not have a very complex library (if I have one at all). I would really appreciate any help on this. Thanks!
    Attached Files
  • Chipper
    Senior Member
    • Mar 2008
    • 323

    #2
    The BioAnalyzer does not have the sensitivity to detect unamplified ChIP samples in most cases.

    Comment

    • ash_5760
      Junior Member
      • Aug 2012
      • 3

      #3
      So then what is the high molecular weight band?

      Comment

      • Hamid
        Senior Member
        • Sep 2009
        • 108

        #4
        Hi Ashely,

        As we discussed on the phone, you are:
        1. using too many cells for the microTUBE. The microTUBE is designed for only processing nuclei from 3 million cells or less in the 130ul volume. You will need to process 10^7 cells in 1ml volume using our 12x12 tube.
        2. you are using the wrong settings. when processing in microTUBEs, we have optimized a setting of 2%duty cycle/3 intensity/200cpb for the initial time course.

        Thank you

        Hamid

        Comment

        • ash_5760
          Junior Member
          • Aug 2012
          • 3

          #5
          Hi Hamid,

          If your "optimizations" worked, there wouldn't be any issues...as we discussed. Repetition in a forum is not helpful.

          -Ashley

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          215 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          79 views
          0 reactions
          Last Post SEQadmin2  
          Working...